Lts Lohmann Therapie-Systeme Ag

Lts Lohmann Therapie-Systeme Gmbh

Photonamic Gmbh & Co. Kg

Gerd Hoffmann

Michael Horstmann

Sandra Wiedersberg

Heinrich Kindel

Tobias Jung

Sandra Wiederberg

Walter MÜLLER

The invention relates to a transdermal therapeutic system (TTS), which is suited for the administration of a peptide to a patient through skin treated with ablation. The transdermal therapeutic system includes a back layer and an active substance-containing layer that contains at least one peptide and a carrier substance, preferably as a textile web material.

Transdermal therapeutic system for the administration of peptides

The invention relates to a transdermal therapeutic system, comprising a back layer that is impermeable to an active ingredient, a polymer matrix containing the active ingredient, and a protective layer that can be pulled off, wherein 5-aminolevulinic acid hydrochloride is used as the active ingredient and the basic polymer of the polymer matrix is an adhesive polyacrylate. Said transdermal therapeutic system is suitable for diagnosing and treating preliminary stages of skin cancer, such as actinic keratosis, and oncological skin diseases.

Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride

The invention relates to a transdermal therapeutic system (TTS) for administering pharmaceutical agents through the skin, comprising a back layer (R) impermeable to the agent and at least one layer (S) comprising the agent, wherein the layer (H) facing the skin comprises urea in solid form, allowing continuous administration of large quantities of agent over a long period of time.

Transdermal therapeutic system having urea components

Transdermal therapeutic system with acetylsalicylic acid in crystalline

Growing community of inventors

Neuwied, Germany

Gerd Hoffmann